Management of the Aggressive Patient Refusing Oral Medication

Immediate Pharmacological Management

The American Academy of Emergency Medicine recommends offering oral medication first, but if refused, proceeding immediately to intramuscular administration using either lorazepam, haloperidol, or droperidol as monotherapy for rapid control of acute agitation 1
Lorazepam 2 mg IM is a Level B recommendation as effective monotherapy for the acutely agitated undifferentiated patient 1
Droperidol IM should be considered instead of haloperidol if rapid sedation is required, with a Level B recommendation 1
Haloperidol plus lorazepam IM may produce more rapid sedation than monotherapy in acutely agitated psychiatric patients, with a Level C recommendation 1, 2

The American Academy of Child and Adolescent Psychiatry recommends attempting oral administration first before proceeding to IM injection whenever the clinical situation allows 2
Ensure trained staff are present to safely administer IM medication 2, 5
Have the patient sitting or standing when administering oral medication to avoid aspiration 5
Continuous monitoring by trained nursing personnel is mandatory after chemical restraint administration 2
Face-to-face evaluation by a licensed independent practitioner within 1 hour of chemical restraint administration is required by regulatory standards 5
Assess every 15 minutes for patient status, vital signs, and response to medication 6

Never use chemical restraint as punishment or for staff convenience, only to prevent dangerous behavior to self or others 5
Do not use PRN (as needed) orders for chemical restraint, as each administration requires a specific order from a licensed practitioner 2, 5
Avoid benzodiazepines in patients with suspected substance use disorders unless withdrawal is the primary concern 7
Watch for paradoxical rage reactions with anxiolytics and antihistamines, particularly in children and adolescents 2

Transition to oral antipsychotics for patients with known psychiatric illness requiring ongoing treatment 1
Conduct debriefing with the patient once they have regained self-control to identify triggers and develop prevention strategies 2, 6
Reassess for underlying medical conditions that may be causing or exacerbating psychiatric symptoms, as 46% of psychiatric patients have medical illnesses contributing to their presentation 1